Pharmacokinetic/pharmacodynamic relationship of eptazocine, a narcotic-antagonist analgesic, in rats
Related Experiment Video
Updated: Oct 9, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
T Suzuki1, R Shimizu, T Suganuma
1Department of Pharmaceutics, College of Pharmacy, Nihon University, Funabashi, Chiba, Japan. t-suzuki@pha.nihon-u.ac.jp
Abstract:
The relationship between the pharmacokinetics and the pharmacodynamics of eptazocine, a narcotic-antagonist analgesic, was investigated in rats. The analgesic effect of eptazocine (2.5, 5 and 10 mg/kg) following intravenous (i.v) administration was evaluated by both the Randall-Selitto method and the D'Amour-Smith method. The analgesic effects were determined before and at designed intervals for a period of 120 min after eptazocine administration, and are expressed as area under the effect-time curve (AUC(E)). The plasma concentration of eptazocine was determined by fluorescence HPLC and was analyzed with a two compartment open model using the nonlinear least-squares method. Eptazocine produced a dose-dependent analgesic effect. It was demonstrated that eptazocine has a linear relationship between AUC(E) and the area under the plasma concentration-time curve (AUC) following i.v. administration for three different doses ranging from 2.5 to 10 mg/kg.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacokinetic–Pharmacodynamic Relationship: Model Components

